CellSource Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3423580004
JPY
320.00
-377 (-54.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Apr'26
Jan'26
Oct'25
Jul'25
Apr'25
Jan'25
Oct'24
Net Sales
915.57
860.02
893.36
997.59
971.32
849.19
1,013.68
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
915.57
860.02
893.36
997.59
971.32
849.19
1,013.68
Raw Material Cost
380.12
350.70
402.89
421.95
415.79
383.34
716.15
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.19
0.29
0.24
0.51
0.27
0.29
0.31
Selling and Distribution Expenses
469.37
449.68
447.12
469.35
476.28
528.01
556.50
Other Expenses
-0.02
-0.03
-0.02
-0.05
-0.03
-0.03
-0.03
Total Expenditure (Excl Depreciation)
849.49
800.38
850.01
891.31
892.08
911.35
1,272.65
Operating Profit (PBDIT) excl Other Income
66.10000000000001
59.6
43.4
106.30000000000001
79.2
-62.199999999999996
-259
Other Income
-7.72
-2.19
-19.09
2.32
-1.34
0.72
0.26
Operating Profit (PBDIT)
102.91
101.17
80.39
157.94
124.09
-8.79
-206.75
Interest
0.19
0.29
0.24
0.51
0.27
0.29
0.31
Exceptional Items
-0.74
-6.24
-47.94
2.60
2.82
4.36
4.60
Gross Profit (PBDT)
535.45
509.31
490.47
575.64
555.52
465.85
297.53
Depreciation
44.55
43.73
56.13
49.34
46.18
52.66
51.96
Profit Before Tax
57.43
50.90
-23.91
110.69
80.45
-57.38
-254.42
Tax
19.86
17.28
51.70
35.58
23.81
-11.91
-118.15
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
37.57
33.62
-75.62
75.10
56.64
-45.46
-136.27
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
37.57
33.62
-75.62
75.10
56.64
-45.46
-136.27
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
37.57
33.62
-75.62
75.10
56.64
-45.46
-136.27
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
5,992.76
5,950.81
6,016.83
6,094.11
5,947.64
5,893.93
6,037.10
Earnings per share (EPS)
1.89
1.69
-3.82
3.78
2.86
-2.3
-6.88
Diluted Earnings per share
1.89
1.69
-3.82
3.78
2.86
-2.3
-6.88
Operating Profit Margin (Excl OI)
7.22%
6.93%
4.85%
10.65%
8.16%
-7.32%
-25.55%
Gross Profit Margin
11.14%
11.0%
3.61%
16.04%
13.04%
-0.56%
-19.97%
PAT Margin
4.1%
3.91%
-8.46%
7.53%
5.83%
-5.35%
-13.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Apr 2026 is 6.47% vs -3.74% in Jan 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Apr 2026 is 11.90% vs 144.44% in Jan 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Apr 2026 is 6.96% vs 3.92% in Jan 2026

stock-summary

Interest

QoQ Growth in quarter ended Apr 2026 is -33.33% vs 50.00% in Jan 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Apr 2026 has improved from Jan 2026

Compare Quarterly Results Of CellSource Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
915.57
14,762.99
-13,847.42
-93.80%
Other Operating Income
0.00
0.00
0.00
Total Operating income
915.57
14,762.99
-13,847.42
-93.80%
Raw Material Cost
380.12
11,478.58
-11,098.46
-96.69%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.19
14.12
-13.93
-98.65%
Selling and Distribution Expenses
469.37
2,084.65
-1,615.28
-77.48%
Other Expenses
-0.02
-1.41
1.39
98.58%
Total Expenditure (Excl Depreciation)
849.49
13,563.23
-12,713.74
-93.74%
Operating Profit (PBDIT) excl Other Income
66.08
1,199.76
-1,133.68
-94.49%
Other Income
-7.72
-4.78
-2.94
-61.51%
Operating Profit (PBDIT)
102.91
1,310.32
-1,207.41
-92.15%
Interest
0.19
14.12
-13.93
-98.65%
Exceptional Items
-0.74
0.00
-0.74
Gross Profit (PBDT)
535.45
3,284.41
-2,748.96
-83.70%
Depreciation
44.55
115.33
-70.78
-61.37%
Profit Before Tax
57.43
1,180.86
-1,123.43
-95.14%
Tax
19.86
387.59
-367.73
-94.88%
Provisions and contingencies
0
0
0.00
Profit After Tax
37.57
788.74
-751.17
-95.24%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
37.57
788.74
-751.17
-95.24%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
4.54
-4.54
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
37.57
793.27
-755.70
-95.26%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
5,992.76
15,349.42
-9,356.66
-60.96%
Earnings per share (EPS)
1.89
13.04
-11.15
-85.51%
Diluted Earnings per share
1.89
13.04
-11.15
-85.51%
Operating Profit Margin (Excl OI)
7.22%
8.13%
0.00
-0.91%
Gross Profit Margin
11.14%
8.78%
0.00
2.36%
PAT Margin
4.10%
5.34%
0.00
-1.24%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 91.56 Million
in Apr 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Apr 2026 is 6.47% vs -3.74% in Jan 2026

stock-summary

YoY Growth in quarter ended Apr 2026 is -5.73% vs -7.86% in Apr 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.76 Million
in Apr 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Apr 2026 is 11.90% vs 144.44% in Jan 2026

stock-summary

YoY Growth in quarter ended Apr 2026 is -33.57% vs -63.74% in Apr 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.06 Million
in Apr 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Apr 2026 is 6.96% vs 3.92% in Jan 2026

stock-summary

YoY Growth in quarter ended Apr 2026 is -11.80% vs 18.30% in Apr 2025

Quarterly - Interest
Interest 0.02 Million
in Apr 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Apr 2026 is -33.33% vs 50.00% in Jan 2026

stock-summary

YoY Growth in quarter ended Apr 2026 is -33.33% vs -25.00% in Apr 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.22%
in Apr 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Apr 2026 has improved from Jan 2026

stock-summary

YoY Growth in quarter ended Apr 2026 has fallen from Apr 2025